Interactions of liposomes with cells in vitro and in vivo:: Opsonins and receptors

被引:69
作者
Ishida, T [1 ]
Harashima, H
Kiwada, H
机构
[1] Univ Tokushima, Fac Pharmaceut Sci, Dept Pharmacokinet & Biopharmaceut, Tokushima 7708505, Japan
[2] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Design & Pharmaceut, Sapporo, Hokkaido 0600812, Japan
关键词
D O I
10.2174/1389200013338306
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of studies have appeared recently on the underlying mechanisms of liposome cell interactions under in vitro conditions, in which isolated cell populations or cell lines NN ed. However, our knowledge of how liposomes interact with cells and the parameters that influence this in vivo is limited. We will summarize and discuss the relevant studies on this matter in this article. In addition, researchers in this field have long been aware of the interaction of liposomes with blood (or serum/plasma) proteins In vivo and their potential role in the process of the clearance of liposomes from the circulation. Some of the 'opsonizing' proteins, such as complement components, immunoglobulins, which enhance the interactions of liposomes with 'phagocytic cells' have been identified. However, the issue of which types of opsonins determine the fate of liposomes in vivo and how liposomal physicochemical properties such as size, charge and fluidity play an important role in the process of liposome clearance is not clear. Our own observations of one of opsonins, complement component are reviewed herein. As opposed to the fate of conventional liposomes, we briefly touch on the interaction of surface-modified liposomes, which are designed to avoid interactions with blood proteins and/or cells (sterically stabilized liposomes, long-circulating liposomes) and to actively target specific cells or tissues (targeted liposomes: immunoliposomes). Blood proteins such as opsonins are not usually thought to play an important role in the clearance of such liposomes.
引用
收藏
页码:397 / 409
页数:13
相关论文
共 139 条
[1]  
ACTON SL, 1994, J BIOL CHEM, V269, P21003
[2]  
AHMAD I, 1992, CANCER RES, V52, P4817
[3]  
AHMAD I, 1993, CANCER RES, V53, P1484
[4]  
Allen Theresa M., 1994, Journal of Liposome Research, V4, P1, DOI 10.3109/08982109409037027
[5]   UPTAKE OF LIPOSOMES BY CULTURED MOUSE BONE-MARROW MACROPHAGES - INFLUENCE OF LIPOSOME COMPOSITION AND SIZE [J].
ALLEN, TM ;
AUSTIN, GA ;
CHONN, A ;
LIN, L ;
LEE, KC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1061 (01) :56-64
[6]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[7]   A NEW STRATEGY FOR ATTACHMENT OF ANTIBODIES TO STERICALLY STABILIZED LIPOSOMES RESULTING IN EFFICIENT TARGETING TO CANCER-CELLS [J].
ALLEN, TM ;
BRANDEIS, E ;
HANSEN, CB ;
KAO, GY ;
ZALIPSKY, S .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1237 (02) :99-108
[8]   LARGE UNILAMELLAR LIPOSOMES WITH LOW UPTAKE INTO THE RETICULOENDOTHELIAL SYSTEM [J].
ALLEN, TM ;
CHONN, A .
FEBS LETTERS, 1987, 223 (01) :42-46
[9]  
ALLEN TM, 1998, TARGETED STERICALLY
[10]   IMMUNE CLEARANCE OF LIPOSOMES INHIBITED BY AN ANTI-FC RECEPTOR ANTIBODY INVIVO [J].
ARAGNOL, D ;
LESERMAN, LD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2699-2703